GHSI logo

Guardion Health Sciences, Inc. Stock Price

OTCPK:GHSI Community·US$4.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GHSI Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

GHSI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet slight.

4 Risks
1 Reward

Guardion Health Sciences, Inc. Key Details

US$12.2m

Revenue

US$6.8m

Cost of Revenue

US$5.4m

Gross Profit

US$10.7m

Other Expenses

-US$5.3m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-3.91
44.56%
-43.14%
0%
View Full Analysis

About GHSI

Founded
2009
Employees
9
CEO
Mark Goldstone
WebsiteView website
www.guardionhealth.com

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Recent GHSI News & Updates

Recent updates

No updates